As other posters have noted, the patient that passed away lived much longer than expected from her cervical cancer prognosis and subsequently underwent a varienty of other medical treatments (so it is being said). I am loosening up some funds from another stock and I am hoping to add anoter 20% or so to my ADXS holdings today. Keeping the faith!
Thanks Stockhakr! From 14-15 minutes Daniel Oconnor responds to a question about Dendreon stock depreciation and whether we are going to be susceptible to this. He lays out the simplicity and low cost of production (this part is all in English)... as well as a promotion of the efficacy as reported by the Dr. Mason survival curves. Fei Chang Hao!